These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 769605)

  • 1. Cardiovascular effects of cannabinol during oral surgery.
    Gregg JM; Campbell RL; Levin KJ; Ghia J; Elliott RA
    Anesth Analg; 1976; 55(2):203-13. PubMed ID: 769605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of delta9-tetrahydrocannabinol and cannabinol in man.
    Karniol IG; Shirakawa I; Takahashi RN; Knobel E; Musty RE
    Pharmacology; 1975; 13(6):502-12. PubMed ID: 1221432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of diazepam premedication and epinephrine-containing local anesthetic on cardiovascular and plasma catecholamine responses to oral surgery.
    Dionne RA; Goldstein DS; Wirdzek PR
    Anesth Analg; 1984 Jul; 63(7):640-6. PubMed ID: 6731889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions in man of delta-9-tetrahydrocannabinol. II. Cannabinol and cannabidiol.
    Hollister LE; Gillespie H
    Clin Pharmacol Ther; 1975 Jul; 18(1):80-3. PubMed ID: 1097148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of physostigmine and delta-9-tetrahydrocannabinol in man.
    Freemon FR; Rosenblatt JE; EL-Yousef MK
    Clin Pharmacol Ther; 1975 Feb; 17(2):121-6. PubMed ID: 1091392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of cannabidiol on delta-9-tetrahydrocannabinol effects.
    Dalton WS; Martz R; Lemberger L; Rodda BE; Forney RB
    Clin Pharmacol Ther; 1976 Mar; 19(3):300-9. PubMed ID: 770048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cannabis and general anaesthetic agents in mice.
    Chesher GB; Jackson DM; Starmer GA
    Br J Pharmacol; 1974 Apr; 50(4):593-9. PubMed ID: 4280927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestion.
    Benowitz NL; Jones RT
    Clin Pharmacol Ther; 1975 Sep; 18(3):287-97. PubMed ID: 1164818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of delta9-tetrahydrocannabinol with oxymorphone or pentobarbital: Effects on ventilatory control and cardiovascular dynamics.
    Johnstone RE; Lief PL; Kulp RA; Smith TC
    Anesthesiology; 1975 Jun; 42(6):674-84. PubMed ID: 48348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous tetrahydrocannabinol on experimental and surgical pain. Psychological correlates of the analgesic response.
    Raft D; Gregg J; Ghia J; Harris L
    Clin Pharmacol Ther; 1977 Jan; 21(1):26-33. PubMed ID: 832447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of marijuana in relation to stress-response mechanisms in the dental patient.
    Horowitz LG; Nersasian RR
    J Am Dent Assoc; 1978 Jun; 96(6):983-6. PubMed ID: 209072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic interaction between cannabinol and delta9-tetrahydrocannabinol.
    Takahashi RN; Karniol IG
    Psychopharmacologia; 1975; 41(3):277-84. PubMed ID: 168604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytohemagglutinin-induced lymphocyte transformation in humans receiving delta9-tetrahydrocannabinol.
    Lau RJ; Tubergen DG; Barr M; Domino EF; Benowitz N; Jones RT
    Science; 1976 May; 192(4241):805-7. PubMed ID: 1265484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydrocannabinol Does Not Reduce Pain in Patients With Chronic Abdominal Pain in a Phase 2 Placebo-controlled Study.
    de Vries M; van Rijckevorsel DCM; Vissers KCP; Wilder-Smith OHG; van Goor H;
    Clin Gastroenterol Hepatol; 2017 Jul; 15(7):1079-1086.e4. PubMed ID: 27720917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divided attention performance of cannabis users and non-users following cannabis and alcohol.
    Macavoy MG; Marks DF
    Psychopharmacologia; 1975 Oct; 44(2):147-52. PubMed ID: 1105631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of several anesthetic agents on the effect of delta9-tetrahydrocannabinol on the heart rate and blood pressure of the mongrel dog.
    Jandhyala BS; Buckley JP
    Eur J Pharmacol; 1977 Jul; 44(1):9-16. PubMed ID: 885163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic administration of delta9-tetrahydrocannabinol on the heart rate of mongrel dogs.
    Jandhyala BS; Malloy KP; Buckley JP
    Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):201-4. PubMed ID: 935652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial.
    Englund A; Atakan Z; Kralj A; Tunstall N; Murray R; Morrison P
    J Psychopharmacol; 2016 Feb; 30(2):140-51. PubMed ID: 26577065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
    Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
    J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.